Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FK474
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,573
Award facts
- Contract value 100% obligated
- $32,572.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,572.63 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulation. This non-set-aside, competitively awarded contract was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and employs firm fixed pricing. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal medical procurement.
This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, represents the type of specialty pharmaceutical commodity that AmerisourceBergen regularly procures through its prime vendor arrangement with the Defense Logistics Agency Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FK474?
SPE2DR26FK474 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FK474 worth?
The government has obligated $32,573 on SPE2DR26FK474.
Is contract SPE2DR26FK474 an order under another contract?
Yes. SPE2DR26FK474 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK474 competed?
The extent of competition for SPE2DR26FK474 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award